Guest Editorial: Understanding of MPN and MDS/MPN based on molecular pathogenesis and clinical aspects

Int J Hematol. 2017 Jun;105(6):709-710. doi: 10.1007/s12185-017-2244-y. Epub 2017 Apr 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Calreticulin / genetics
  • Carrier Proteins / genetics
  • Humans
  • Janus Kinase 2 / genetics
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
  • Leukemia, Myelomonocytic, Chronic
  • Leukemia, Myelomonocytic, Juvenile
  • Molecular Targeted Therapy
  • Mutation
  • Myelodysplastic-Myeloproliferative Diseases* / genetics
  • Myeloproliferative Disorders* / genetics
  • Nuclear Proteins / genetics
  • Phosphoproteins / genetics
  • RNA Splicing Factors / genetics
  • Receptors, Thrombopoietin / genetics
  • Repressor Proteins / genetics

Substances

  • ASXL1 protein, human
  • Calreticulin
  • Carrier Proteins
  • Nuclear Proteins
  • Phosphoproteins
  • RNA Splicing Factors
  • Receptors, Thrombopoietin
  • Repressor Proteins
  • SETBP1 protein, human
  • SF3B1 protein, human
  • MPL protein, human
  • JAK2 protein, human
  • Janus Kinase 2